Port Moody, Canada

Jianxiong Li

USPTO Granted Patents = 10 


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • Port Moody, BC, CA (1996)
  • Port Moody, B. C., CA (1998)
  • Port Moody, CA (2000 - 2015)

Company Filing History:


Years Active: 1996-2015

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jianxiong Li

Introduction

Jianxiong Li is a prominent inventor based in Port Moody, CA. He has made significant contributions to the field of therapeutic compounds, holding a total of 10 patents. His work focuses on developing novel compounds that address critical health issues, particularly in cancer and immune diseases.

Latest Patents

Among his latest patents, Jianxiong Li has developed dithiolopyrrolones with therapeutic activity. This invention provides novel dithiolopyrrolone compounds and their salts, which are useful as treatments for cancer and other proliferative diseases. Additionally, he has created 1,2-diphenylethene derivatives for the treatment of immune diseases. This invention includes novel 1,2-diphenylethene derivatives and pharmaceutically acceptable salts, which serve as modulators of T-cells, neutrophils, and macrophages, aiding in the treatment of immune, inflammatory, and auto-immune diseases.

Career Highlights

Jianxiong Li has worked with Welichem Biotech Inc., where he has contributed to the development of innovative therapeutic solutions. His expertise in medicinal chemistry and drug development has positioned him as a valuable asset in the biotechnology sector.

Collaborations

Throughout his career, Jianxiong Li has collaborated with notable professionals, including Genhui Chen and John M Webster. These collaborations have further enhanced his research and development efforts in the field of therapeutics.

Conclusion

Jianxiong Li's innovative work and numerous patents reflect his dedication to advancing medical science. His contributions to the development of therapeutic compounds are paving the way for new treatments in critical health areas.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…